OPTICAL COHERENCE TOMOGRAPHY, FLUORESCEIN ANGIOGRAPHY, AND DIAGNOSIS OF CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION
暂无分享,去创建一个
E. Vicaut | A. Erginay | G. Quentel | R. Tadayoni | V. Gualino | Salomon Y. Cohen | F. Fajnkuchen | B. Haouchine | V. Krivosic | A. Gaudric | S. Cohen
[1] S. Wolf,et al. Angiographic findings in patients with exudative age-related macular degeneration , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.
[2] S. J. Talks,et al. Correlation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes , 2005, British Journal of Ophthalmology.
[3] Z. Koshy,et al. Use of optical coherence tomography, fluorescein angiography and indocyanine green angiography in a screening clinic for wet age-related macular degeneration , 2006, British Journal of Ophthalmology.
[4] William J Feuer,et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2007, American journal of ophthalmology.
[5] N. Bressler. Antiangiogenic approaches to age-related macular degeneration today. , 2009, Ophthalmology.
[6] Philip J Rosenfeld,et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. , 2009, American journal of ophthalmology.
[7] R. Zawadzki,et al. High-resolution Fourier-domain optical coherence tomography of choroidal neovascular membranes associated with age-related macular degeneration. , 2010, Investigative ophthalmology & visual science.
[8] K Bailey Freund,et al. Do We Need a New Classification for Choroidal Neovascularization in Age-Related Macular Degeneration? , 2010, Retina.
[9] E. Chew,et al. Optical coherence tomography-based decision making in exudative age-related macular degeneration: comparison of time- vs spectral-domain devices , 2009, Eye.
[10] N. Bressler,et al. Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization. , 2010, Ophthalmology.
[11] Neovascular age-related macular degeneration: decision making and optimal management , 2010, Eye.
[12] Joan W. Miller,et al. Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization. , 2011, Investigative ophthalmology & visual science.
[13] Sandra S Stinnett,et al. Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials. , 2012, Ophthalmology.
[14] M. Macsai,et al. PILOT STUDY FOR THE DETECTION OF EARLY EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH OPTICAL COHERENCE TOMOGRAPHY , 2012, Retina.
[15] Sharon D. Solomon,et al. Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study. , 2012, Ophthalmology.
[16] Y. Yang,et al. Optical coherence tomography changes before the development of choroidal neovascularization in second eyes of patients with bilateral wet macular degeneration , 2012, Eye.
[17] Adnan Tufail,et al. Evaluation of age-related macular degeneration with optical coherence tomography. , 2012, Survey of ophthalmology.
[18] D. Do. Detection of new-onset choroidal neovascularization , 2013, Current opinion in ophthalmology.
[19] Jesse J. Jung,et al. The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration. , 2014, American journal of ophthalmology.
[20] Glenn J Jaffe,et al. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. , 2014, Ophthalmology.
[21] C. Wykoff,et al. COMPARISON OF SPECTRAL-DOMAIN AND TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY IN THE DETECTION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION ACTIVITY , 2014, Retina.
[22] Francesco Bandello,et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) , 2014, British Journal of Ophthalmology.
[23] W. Amoaku,et al. The diagnostic accuracy of spectral-domain optical coherence tomography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography , 2015, Eye.
[24] C. Ramsay,et al. Optical coherence tomography for the monitoring of neovascular age-related macular degeneration: a systematic review. , 2015, Ophthalmology.
[25] K Bailey Freund,et al. A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization. , 2016, Investigative ophthalmology & visual science.
[26] Philip J. Rosenfeld,et al. Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular Degeneration , 2016, Investigative ophthalmology & visual science.
[27] Francesco Bandello,et al. Optical Coherence Tomography Angiography: A Useful Tool for Diagnosis of Treatment-Naïve Quiescent Choroidal Neovascularization. , 2016, American journal of ophthalmology.
[28] U. Schmidt-Erfurth,et al. A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration , 2017, Eye.
[29] Salomon Y. Cohen,et al. Imaging of Exudative Age-Related Macular Degeneration: Toward a Shift in the Diagnostic Paradigm? , 2017, Retina.